Intrinsic subtypes and risk scores in ER+/HER2-Breast Cancer: a comparison of Prosigna and OncotypeDX risk categories with Ki67. (March 2017) - Sinn, P.; Schneeweiss, A.; Endris, V.; Penzel, R.; Schirmacher, P.; Kirchner, M.; Stenzinger, A.